全文获取类型
收费全文 | 2901篇 |
免费 | 179篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 72篇 |
妇产科学 | 100篇 |
基础医学 | 461篇 |
口腔科学 | 131篇 |
临床医学 | 261篇 |
内科学 | 655篇 |
皮肤病学 | 17篇 |
神经病学 | 212篇 |
特种医学 | 65篇 |
外科学 | 483篇 |
综合类 | 40篇 |
预防医学 | 149篇 |
眼科学 | 28篇 |
药学 | 152篇 |
中国医学 | 7篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 20篇 |
2022年 | 35篇 |
2021年 | 83篇 |
2020年 | 45篇 |
2019年 | 81篇 |
2018年 | 83篇 |
2017年 | 56篇 |
2016年 | 82篇 |
2015年 | 70篇 |
2014年 | 110篇 |
2013年 | 143篇 |
2012年 | 247篇 |
2011年 | 247篇 |
2010年 | 161篇 |
2009年 | 134篇 |
2008年 | 199篇 |
2007年 | 191篇 |
2006年 | 191篇 |
2005年 | 185篇 |
2004年 | 170篇 |
2003年 | 122篇 |
2002年 | 126篇 |
2001年 | 18篇 |
2000年 | 11篇 |
1999年 | 27篇 |
1998年 | 17篇 |
1997年 | 25篇 |
1996年 | 17篇 |
1995年 | 16篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 18篇 |
1991年 | 14篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 10篇 |
1987年 | 11篇 |
1986年 | 5篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 4篇 |
1982年 | 9篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 13篇 |
1977年 | 5篇 |
1973年 | 3篇 |
1964年 | 3篇 |
1894年 | 3篇 |
排序方式: 共有3102条查询结果,搜索用时 15 毫秒
51.
A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome 总被引:2,自引:0,他引:2
Wölfler A Erkeland SJ Bodner C Valkhof M Renner W Leitner C Olipitz W Pfeilstöcker M Tinchon C Emberger W Linkesch W Touw IP Sill H 《Blood》2005,105(9):3731-3736
The granulocyte colony-stimulating factor receptor (G-CSF-R) transmits signals for proliferation and differentiation of myeloid progenitor cells. Here we report on the identification of a rare single nucleotide polymorphism within its intracellular domain (G-CSF-R_Glu785Lys). Screening a cohort of 116 patients with primary myelodysplastic syndromes (MDS), de novo acute myeloid leukemia (AML) (84 patients), as well as 232 age- and sex-matched controls revealed a highly significant association of the G-CSF-R_785Lys allele with the development of high-risk MDS as defined by more than 5% bone marrow blasts (9.7% versus 0.9% in controls; P = .001; odds ratio [OR], 12.5; 95% confidence interval [CI], 2.4-58.9) or an International Prognostic Scoring System score of intermediate-2 or high (13.0% versus 0.9%; P < .001; OR, 14.0; 95% CI, 3.4-85.0). Functional analysis by retroviral transfer of G-CSF-R_785Lys into myeloid progenitor cells of G-CSF-R-deficient mice showed a significantly diminished colony-formation capacity after G-CSF stimulation as compared with cells transduced with the wild-type receptor. These results suggest that lifelong altered G-CSF response by the G-CSF-R_785Lys may render individuals susceptible to development of high-risk MDS. 相似文献
52.
53.
Die Innere Medizin - Die hausarztzentrierte Versorgung (HZV) wurde auf Grundlage der GKV-Modernisierungsgesetze (GKV gesetzliche Krankenversicherung) von 2004 und 2007 in die ambulante Versorgung... 相似文献
54.
55.
Olinda Maria Rodrigues de Araujo Maria Lúcia Ivo Marcos Antonio Ferreira Júnior Elenir Rose Jardim Cury Pontes Ieda Maria Gon?alves Pacce Bispo Eveny Cristine Luna de Oliveira 《Revista latino-americana de enfermagem》2015,23(1):67-73
OBJECTIVE:
to estimate survival, mortality and cause of death among users or not of hydroxyurea with sickle cell disease.METHOD:
cohort study with retrospective data collection, from 1980 to 2010 of patients receiving inpatient treatment in two Brazilian public hospitals. The survival probability was determined using the Kaplan-Meier estimator, survival calculations (SPSS version 10.0), comparison between survival curves, using the log rank method. The level of significance was p=0.05.RESULTS:
of 63 patients, 87% had sickle cell anemia, with 39 using hydroxyurea, with a mean time of use of the drug of 20.0±10.0 years and a mean dose of 17.37±5.4 to 20.94±7.2 mg/kg/day, raising the fetal hemoglobin. In the comparison between those using hydroxyurea and those not, the survival curve was greater among the users (p=0.014). A total of 10 deaths occurred, with a mean age of 28.1 years old, and with Acute Respiratory Failure as the main cause.CONCLUSION:
the survival curve is greater among the users of hydroxyurea. The results indicate the importance of the nurse incorporating therapeutic advances of hydroxyurea in her care actions. 相似文献56.
Jaume Francisco-Pascual Eduard Rodenas Yassin Belahnech Nuria Rivas-Gándara Jordi Pérez-Rodon Alba Santos-Ortega Begoña Benito Ivo Roca-Luque Yolima Cossio-Gil Vicens Serra Garcia Sandra Llerena-Butron Julian Rodríguez-García Angel Moya-Mitjans David García-Dorado Ignacio Ferreira-González 《The Canadian journal of cardiology》2021,37(2):284-291
BackgroundSevere aortic stenosis (AoS) is considered a primary cause of syncope. However, other mechanisms may be present in these patients and accurate diagnosis can have important clinical implications. The aim of this study is to assess the different etiologies of syncope in patients with severe AoS and the impact on prognosis of attaining a certain or highly probable diagnosis for the syncope.MethodsOut of a cohort of 331 patients with AoS and syncope, 61 had severe AoS and were included in the study. Main cause of syncope and adverse cardiac events were assessed.ResultsIn 40 patients (65.6%), we reached a certain or highly probable diagnosis of the main cause of the syncope. AoS was considered the primary cause of the syncope in only 7 patients (17.5% of the patients with known etiology). Atrioventricular block (14 patients, 35.0%) and vasovagal syncope (6 patients, 15.0%) were the most frequently diagnosed causes. The presence of a known cause for syncope during the admission was not associated with a lower incidence of recurrence during follow-up (hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.20-2.40). Syncope of unknown etiology was independently associated with greater mortality during 1-year follow-up (HR 5.4, 95% CI 1.3-21.6) and 3-year follow-up (HR 3.5, 95% CI 1.2-10.3).ConclusionsIn a high proportion of patients with severe AoS admitted for syncope, the valvulopathy was not the main cause of the syncope. Syncope in two-thirds of this population was caused by either bradyarrhythmia or reflex causes. Syncope of unknown cause was associated with increased short- and medium-term mortality, independently from treatment of the valve disease. An exhaustive work-up should be conducted to determine the main cause for syncope. 相似文献
57.
Suriani R Venturini I Actis GC Rocca G Rizzetto M Cerutti E Mazzucco D Cardesi E Zeneroli ML 《Hepato-gastroenterology》2004,51(55):176-180
BACKGROUND/AIMS: Duodenal gastric metaplasia seems to be linked to infection by Helicobacter pylori, to the extent of acid secretion and to bulbitis. An investigation was made of the relationship between bulbitis and duodenal gastric metaplasia, or whether bulbitis can arise along with duodenal gastric metaplasia after Helicobacter pylori eradication in an average of six years. METHODOLOGY: We compared 22 patients with duodenal ulcers [male/female 16/6; (mean age+/-SD) 55+/-12 years] Helicobacter pylori-negative after eradication, with 23 Helicobacter pylori-positive patients free from active duodenal ulcers [male/female 17/6; (mean age+/-SD) 59+/-12 years]. RESULTS: The bulbitis score was found to be lower in the Helicobacter pylori-negative than in the Helicobacter pylori-positive group (p=0.02). The duodenal gastric metaplasia score in the Helicobacter pylori-negative was higher than in the Helicobacter pylori-positive group (p=0.001). We failed to find any relationship between the presence of bulbitis and duodenal gastric metaplasia. We found a non-significant inverse correlation between the presence of duodenal gastric metaplasia and chronic body gastritis (p=0.07). CONCLUSIONS: Bulbitis and duodenal gastric metaplasia may depend on different causal factors not related to Helicobacter pylori infection. The extension of duodenal gastric metaplasia with time following recovery from peptic ulcer disease may represent a mucosal protection factor against acid. 相似文献
58.
59.
Ulrike Schliesser Martin Chopra Andreas Beilhack Christine Appelt Simone Vogel Julia Schumann Ivo Panov Katrin Vogt Stephan Schlickeiser Sven Olek Kathryn Wood Christine Brandt Hans‐Dieter Volk Birgit Sawitzki 《European journal of immunology》2013,43(12):3291-3305
The transfer of alloreactive regulatory T (aTreg) cells into transplant recipients represents an attractive treatment option to improve long‐term graft acceptance. We recently described a protocol for the generation of aTreg cells in mice using a nondepleting anti‐CD4 antibody (aCD4). Here, we investigated whether adding TGF‐β and retinoic acid (RA) or rapamycin (Rapa) can further improve aTreg‐cell generation and function. Murine CD4+ T cells were cultured with allogeneic B cells in the presence of aCD4 alone, aCD4+TGF‐β+RA or aCD4+Rapa. Addition of TGF‐β+RA or Rapa resulted in an increase of CD25+Foxp3+‐expressing T cells. Expression of CD40L and production of IFN‐γ and IL‐17 was abolished in aCD4+TGF‐β+RA aTreg cells. Additionally, aCD4+TGF‐β+RA aTreg cells showed the highest level of Helios and Neuropilin‐1 co‐expression. Although CD25+Foxp3+ cells from all culture conditions displayed complete demethylation of the Treg‐specific demethylated region, aCD4+TGF‐β+RA Treg cells showed the most stable Foxp3 expression upon restimulation. Consequently, aCD4+TGF‐β+RA aTreg cells suppressed effector T‐cell differentiation more effectively in comparison to aTreg cells harvested from all other cultures, and furthermore inhibited acute graft versus host disease and especially skin transplant rejection. Thus, addition of TGF‐β+RA seems to be superior over Rapa in stabilising the phenotype and functional capacity of aTreg cells. 相似文献